Lipella Pharmaceuticals Inc. (LIPO) Net margin 2021–2024
Lipella Pharmaceuticals Inc. (LIPO) net profit margin by fiscal year — reported net income divided by reported revenue.
-935.2%FY2024 · since FY2021: -719.3% → -935.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -935.2% | +92.1 pp |
| FY2023 | -1027.3% | +383.3 pp |
| FY2022 | -1410.6% | -691.3 pp |
| FY2021 | -719.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice